Rayner is readying for the global launch of RayPRO+ at the upcoming ESCRS 2022 Congress in Milan, Italy. RayPRO is a mobile app and web-based digital platform that proactively collects a variety of patient reported outcomes (PROs) during a three-year period.
In RayPRO+, patient outcomes with IOLs other than Rayner can also be recorded, giving surgeons a more full view with comparative data. According to Rayner, the app includes clear reports that are given in real-time via the RayPRO+ dashboard, which can be accessed from any location at any time.
“Since launching RayPRO in 2019, we have been closely listening to feedback from surgeons which has resulted in numerous enhancements to the platform," Rayner CEO Tim Clover said in a company news release.
"RayPRO+ is by far the biggest evolution to date and has been facilitated by Wolffsohn Research, our software development partner led by Professor James Wolffsohn. I have long believed that decisions within ophthalmology should be based upon large data sets, which is why I’m excited to now offer RayPRO+ to surgeons who are interested in collecting Big Data about their patients’ outcomes, but who may not be current or exclusive users of Rayner IOLs,” Mr. Clover added.
RayPRO+ will replace Rayner's Raytrace online lens calculator as its flagship digital solution.
According to Rayner, all surgeons who sign up for RayPRO+ at the ESCRS meeting will receive six months of free access. RayPRO+ is free for Rayner IOL subscribers, but it costs £49.99 per month for everyone else.
Surgeons are invited to experience RayPRO+ for themselves by visiting the Rayner booth (C11, Hall 4) at the ESCRS Congress in Milan.